Mucormycosis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 6: | Line 6: | ||
Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly. | Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly. | ||
==Primary Prevention for Mucormycosis== <ref name=" | ==Primary Prevention for Mucormycosis== | ||
Some preventive strategies may help in decreasing the risk of infection with causative organisms of mucormycosis, such as:<ref name="urlPeople at Risk For Mucormycosis | Mucormycosis | CDC">{{cite web |url=https://www.cdc.gov/fungal/diseases/mucormycosis/risk-prevention.html |title=People at Risk For Mucormycosis | Mucormycosis | CDC |format= |work= |accessdate=}}</ref> | |||
* Balanced use of immunosuppressants like corticosteroids. | * Balanced use of [[immunosuppressants]] like [[corticosteroids]]. | ||
* Adequate control of blood glucose levels in diabetes. | * Adequate control of blood glucose levels in [[DM|diabetes]]. | ||
* Using rooms equipped with high-efficiency particulate air (HEPA) filtration and using masks for patients with severe immunosuppression. | * Using rooms equipped with high-efficiency particulate air ([[HEPA]]) filtration and using masks for patients with severe [[immunosuppression]]. | ||
* Treating the underlying chronic disorder leading to debilitation of the patient. | * Treating the underlying chronic disorder leading to debilitation of the patient. | ||
* Using sterilized and decontaminated wound dressings in high risk patients. | * Using [[Sterilization (surgical procedure)|sterilized]] and decontaminated wound dressings in high-risk patients. | ||
==References== | ==References== | ||
| Line 19: | Line 19: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Nephrology]] | |||
[[Category:Dermatology]] | |||
[[Category:Pulmonology]] | |||
Latest revision as of 22:46, 29 July 2020
|
Mucormycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly.
Primary Prevention for Mucormycosis
Some preventive strategies may help in decreasing the risk of infection with causative organisms of mucormycosis, such as:[1]
- Balanced use of immunosuppressants like corticosteroids.
- Adequate control of blood glucose levels in diabetes.
- Using rooms equipped with high-efficiency particulate air (HEPA) filtration and using masks for patients with severe immunosuppression.
- Treating the underlying chronic disorder leading to debilitation of the patient.
- Using sterilized and decontaminated wound dressings in high-risk patients.